Alembic Ltd

Alembic Ltd

₹ 136 -0.08%
24 Dec - close price
About

Alembic Limited is engaged in the businesses of Pharmaceuticals, Real Estate, and Power Assets. The company was started in 1907 as the flagship company of the Alembic Group. In 2010, the company demerged its core pharmaceutical business (formulations) into a wholly-owned subsidiary, Alembic Pharma Ltd and after the demerger, APL became the flagship company of the Alembic Group.
With its registered office in Vadodra, Alembic Ltd currently holds a 28.41% stake in Alembic Pharma Ltd and a 19.01% stake in another group entity Paushak Limited.[1]

Key Points

Business Segments
A) Real Estate (~80% in FY24 vs 59% in FY22): [1] [2] The company is involved in the construction of residential & commercial real estate projects. It also leases commercial properties. [3] Real Estate business experienced strong growth between FY23-FY24 bolstered by strong demand and higher property prices. [4]

  • Market Cap 3,489 Cr.
  • Current Price 136
  • High / Low 169 / 78.1
  • Stock P/E 27.8
  • Book Value 33.0
  • Dividend Yield 1.77 %
  • ROCE 12.4 %
  • ROE 11.2 %
  • Face Value 2.00

Pros

  • Company is almost debt free.
  • Company is expected to give good quarter
  • Company has delivered good profit growth of 18.1% CAGR over last 5 years
  • Company has been maintaining a healthy dividend payout of 63.8%
  • Debtor days have improved from 60.2 to 41.7 days.
  • Company's working capital requirements have reduced from 146 days to 79.2 days

Cons

  • Stock is trading at 4.11 times its book value
  • Tax rate seems low
  • Company has a low return on equity of 9.84% over last 3 years.
  • Earnings include an other income of Rs.71.6 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
19 19 17 21 36 30 36 36 31 38 48 49 51
17 15 15 16 26 20 23 26 22 25 24 30 33
Operating Profit 3 3 3 5 10 10 13 10 10 13 23 19 18
OPM % 14% 18% 16% 23% 29% 33% 35% 28% 31% 35% 49% 40% 36%
81 2 4 1 59 2 -9 3 48 2 2 2 66
Interest 0 0 0 0 0 0 0 0 0 0 0 0 1
Depreciation 1 1 1 2 2 2 2 2 2 3 1 2 3
Profit before tax 83 4 6 4 68 11 2 11 56 13 24 19 81
Tax % 11% 3% 20% 10% 10% 1% -72% 13% 8% 10% 12% 9% 5%
73 4 5 4 61 10 4 9 51 11 21 17 77
EPS in Rs 2.86 0.15 0.18 0.14 2.37 0.41 0.17 0.37 2.00 0.44 0.81 0.66 2.98
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
179 154 144 134 147 125 124 74 72 76 123 152 186
164 126 134 128 140 114 106 70 62 63 85 96 111
Operating Profit 16 28 10 6 7 11 18 4 11 13 38 56 74
OPM % 9% 18% 7% 5% 5% 9% 15% 5% 15% 17% 31% 37% 40%
10 18 21 25 25 37 29 93 10 89 54 55 72
Interest 5 4 1 0 0 0 0 0 0 0 0 1 1
Depreciation 10 8 6 6 5 4 3 3 4 4 6 7 9
Profit before tax 11 33 23 25 27 44 45 94 17 97 85 103 136
Tax % -4% 12% -3% 2% -3% 5% 8% 0% 19% 12% 7% 10%
11 30 24 25 27 42 41 94 13 86 79 93 125
EPS in Rs 0.43 1.11 0.90 0.93 1.03 1.56 1.60 3.64 0.52 3.34 3.09 3.62 4.89
Dividend Payout % 23% 14% 17% 16% 19% 13% 12% 16% 38% 54% 71% 66%
Compounded Sales Growth
10 Years: 0%
5 Years: 4%
3 Years: 28%
TTM: 40%
Compounded Profit Growth
10 Years: 12%
5 Years: 18%
3 Years: 112%
TTM: 45%
Stock Price CAGR
10 Years: 16%
5 Years: 20%
3 Years: 10%
1 Year: 47%
Return on Equity
10 Years: 9%
5 Years: 10%
3 Years: 10%
Last Year: 11%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 27 53 53 53 53 53 51 51 51 51 51 51 51
Reserves 179 177 211 295 314 395 361 432 775 962 778 757 797
25 22 0 9 0 0 0 0 0 0 0 9 16
113 104 91 64 81 73 57 51 109 130 119 128 172
Total Liabilities 344 356 356 421 449 522 470 534 936 1,144 948 946 1,037
185 178 169 146 171 179 209 225 261 294 318 366 382
CWIP 3 2 2 0 0 0 0 3 6 0 0 1 0
Investments 23 21 35 150 189 276 205 197 581 726 503 411 453
132 155 149 124 89 67 55 109 88 124 127 168 201
Total Assets 344 356 356 421 449 522 470 534 936 1,144 948 946 1,037

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
80 -10 22 10 52 24 22 5 -1 -22 35 25
12 18 5 -5 -47 -23 68 57 -35 23 11 23
-94 -8 -25 -5 -5 -3 -89 -6 -15 -6 -46 -48
Net Cash Flow -2 -0 2 -0 -0 -2 1 56 -52 -5 -0 0

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 37 66 122 76 54 74 40 44 66 72 67 42
Inventory Days 351 1,924 880 659 438 247 289 411 2,112 2,885 5,118 3,694
Days Payable 173 659 200 144 128 125 202 151 675 635 993 1,213
Cash Conversion Cycle 215 1,330 801 591 364 195 126 304 1,504 2,322 4,191 2,523
Working Capital Days 93 200 235 172 39 20 13 28 98 231 127 79
ROCE % 6% 16% 9% 8% 8% 10% 10% 21% 2% 10% 10% 12%

Shareholding Pattern

Numbers in percentages

Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
70.88% 70.88% 70.88% 70.88% 70.88% 70.88% 70.88% 70.88% 70.88% 70.88% 70.88% 70.88%
1.19% 1.12% 1.08% 0.83% 0.82% 0.70% 0.72% 0.85% 0.89% 1.07% 1.42% 1.97%
5.17% 4.69% 4.29% 4.12% 3.94% 3.94% 3.93% 3.40% 0.04% 0.04% 0.04% 0.08%
22.76% 23.31% 23.75% 24.16% 24.34% 24.48% 24.46% 24.87% 28.17% 28.02% 27.66% 27.07%
No. of Shareholders 78,38180,13583,00683,61283,63082,33981,73282,94794,01299,13098,4781,02,249

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents